Comments

Gilead Sciences Stock Price, Quotes and Forecasts

Q: What sector and industry does Gilead Sciences (GILD) operate in?

Gilead Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

GILDNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$110.83

0.850.77%

At close: -

$110.71

-0.12-0.11%

After Hours: 4:58 PM EDT

The dividend Ex-Date was 4 days ago

Gilead Sciences (GILD) Forecast

News Earnings Gilead Sciences (GILD) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Gilead Sciences Stock Price, Quotes and Forecasts | NASDAQ:GILD | Benzinga

Explore Gilead Sciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for GILD.

Open	$110.17
Close	$110.83
Volume / Avg.	4.74M / 9.28M
Day Range	$108.80 - $111.47
52 Wk Range	62.69 - 119.96
Market Cap	$137.72B
P/E Ratio	23.11
Dividend Yield	2.87%
Exchange	NASDAQ
RSI	55
Short Interest	1.68%
Days to Cover	2.75

Recent News

Gilead's HIV Pipeline Gains Traction With Upcoming FDA Decision For HIV-1 Drug

Gilead's HIV drug lenacapavir earns FDA priority review after strong trial results, with the company planning to double U.S. PrEP users by 2035.

Vandana Singh

Wall Street Rips Higher As Tariff Truce Halts US–China Economic Escalation

US-China agree to slash tariffs by over 100%, easing fears of economic slowdown and inflation. Markets cheer with futures rising and yields up.

Piero Cingari

Marjorie Taylor Greene Goes Stock Shopping Again: Here Are 50+ Stocks The Congresswoman Bought

Marjorie Taylor Greene disclosed buying more than 50 stocks in early May. A look at the list and why the congresswoman's past trades have drawn red flags.

Chris Katje

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$110.17
Close	$110.83
Volume / Avg.	4.74M / 9.28M
Day Range	$108.80 - $111.47
52 Wk Range	62.69 - 119.96
Market Cap	$137.72B
P/E Ratio	23.11
Dividend Yield	2.87%
Exchange	NASDAQ
RSI	55
Short Interest	1.68%
Days to Cover	2.75

About Gilead Sciences, Inc.

Sector

Health Care

Industry

Biotechnology

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with t...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Gilead Sciences (GILD) stock?

You can purchase shares of Gilead Sciences (NASDAQ:GILD) through any online brokerage.

View our list of the best stock brokerages

Who are Gilead Sciences (GILD) competitors?

Other companies in Gilead Sciences’s space includes: BeOne Medicines (NASDAQ:ONC), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for Gilead Sciences (GILD) stock?

Gilead Sciences has a consensus price target of $106.59.

What is the current price for Gilead Sciences (GILD)?

The stock price for Gilead Sciences (NASDAQ: GILD) is $110.71 last updated June 16, 2025 at 4:58 PM EDT.

Does Gilead Sciences (GILD) pay a dividend?

A quarterly cash dividend of 0.79 per share of Class A Common Stock. The quarterly cash dividend was payable on June 27, 2025 to stockholders of record on June 13, 2025.

When is Gilead Sciences (NASDAQ:GILD) reporting earnings?

Gilead Sciences’s Q2 earnings are confirmed for Thursday, August 7, 2025.

Is Gilead Sciences (GILD) going to split?

There is no upcoming split for Gilead Sciences.

What sector and industry does Gilead Sciences (GILD) operate in?

Gilead Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.